Want to see TSE:GWAY full AI Analyst Report?
Top Page
Greenway Greenhouse Cannabis Corp.
(GWAY)
Select Model
Select Model
Rating:42Neutral
Price Target:
C$0.09
▼(-49.41% Downside)
Action:Upgraded
Date:09/10/26
The score is primarily held down by weak financial performance—thin gross margin, sizable net losses, negative operating/free cash flow, and elevated leverage with declining equity. Technicals add pressure with a clear downtrend (price below key moving averages and negative MACD), only partially offset by oversold momentum signals. Valuation remains challenged because the company is loss-making (negative P/E) and has no stated dividend support.
Positive Factors
Regulated B2B Cannabis Supply Model
Participation in the regulated cannabis supply chain provides a defined operating framework and established route to market. Its focus on wholesale and licensed buyers can support repeat commercial relationships, while cultivation and processing give the company multiple points of participation across the value chain.
Negative Factors
Low Margins and Persistent Losses
Very thin gross margin and substantial net losses indicate that current sales are not translating into sustainable earnings. This weak profitability reduces internal funding capacity and leaves the company exposed if wholesale pricing, yields, or cultivation costs remain unfavorable over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Regulated B2B Cannabis Supply Model
Participation in the regulated cannabis supply chain provides a defined operating framework and established route to market. Its focus on wholesale and licensed buyers can support repeat commercial relationships, while cultivation and processing give the company multiple points of participation across the value chain.
Read all positive factors
Greenway Greenhouse Cannabis Corp. (GWAY) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$12.02M
Dividend YieldN/A
Average Volume (3M)7.47K
Price to Earnings (P/E)―
Beta (1Y)0.73
Revenue Growth-1.41%
EPS Growth-78.91%
CountryCA
Employees10
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.02
Shares Outstanding133,597,080
10 Day Avg. Volume8,080
30 Day Avg. Volume7,473
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)2.91
Price to Sales (P/S)3.02
P/FCF Ratio-11.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Greenway Greenhouse Cannabis Corp. Business Overview & Revenue Model
Company Description
Greenway Greenhouse Cannabis Corporation specializes in the cultivation, processing, and distribution of dried cannabis flower and kief. This company, established in 2018, operates out of Kingsville, Canada, and is a subsidiary of Sunrite Greenhou...
How the Company Makes Money
Greenway Greenhouse Cannabis Corp. primarily makes money by selling cannabis produced at its cultivation operations into the Canadian regulated supply chain, with revenues largely tied to B2B/wholesale transactions rather than direct-to-consumer r...
Greenway Greenhouse Cannabis Corp. Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
38
Negative
Cash Flow
30
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.06M | 7.45M | 8.95M | 5.23M | 5.62M | 1.98M |
| Gross Profit | 616.88K | 188.40K | 1.68M | -335.38K | 741.99K | 844.02K |
| EBITDA | 70.27K | 446.31K | 972.53K | -2.21M | -632.92K | -1.36M |
| Net Income | -3.06M | -2.56M | -2.06M | -4.72M | -2.61M | -2.92M |
Balance Sheet | ||||||
| Total Assets | 30.42M | 31.01M | 32.26M | 33.09M | 35.30M | 35.63M |
| Cash, Cash Equivalents and Short-Term Investments | 1.13M | 1.14M | 3.14M | 1.53M | 3.64M | 7.48M |
| Total Debt | 15.53M | 15.58M | 15.79M | 16.02M | 13.96M | 16.67M |
| Total Liabilities | 23.28M | 23.26M | 22.21M | 21.17M | 20.36M | 18.77M |
| Stockholders Equity | 7.14M | 7.75M | 10.05M | 11.92M | 14.95M | 16.86M |
Cash Flow | ||||||
| Free Cash Flow | -1.06M | -2.01M | 1.61M | -4.96M | -4.38M | -4.10M |
| Operating Cash Flow | -971.95K | -1.87M | 1.81M | -2.05M | 2.23M | -1.97M |
| Investing Cash Flow | -86.85K | -132.20K | -194.37K | -2.92M | 428.31K | -2.12M |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 2.85M | -6.49M | 8.12M |
Greenway Greenhouse Cannabis Corp. Technical Analysis
Neutral
0.17
Price Trends
0.11
Negative
0.13
Negative
0.15
Negative
Market Momentum
>-0.01
Negative
54.68
Neutral
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GWAY, the sentiment is Neutral. The current price of 0.17 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.11, and above the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 54.68 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:GWAY.
Greenway Greenhouse Cannabis Corp. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | C$31.42M | -18.50 | -4.00% | ― | 16.66% | -1007.41% | |
53 Neutral | C$32.04M | -6.03 | -13.79% | ― | -6.74% | 43.54% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
42 Neutral | C$12.02M | -4.52 | -35.33% | ― | -1.41% | -78.91% | |
41 Neutral | C$11.21M | -2.67 | 28.59% | ― | 0.90% | 57.73% | |
41 Neutral | C$16.13M | -3.70 | -108.44% | ― | -0.23% | -142.54% | |
40 Neutral | C$18.10M | -0.03 | -74.75% | ― | ― | ― |
* Healthcare Sector Average
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.10
-0.10
-50.00%
TSE:AYR.A
Ayr Wellness
0.16
0.00
0.00%
TSE:LABS
MediPharm Labs
0.07
0.00
0.00%
TSE:PCLO
PharmaCielo
0.05
<0.01
11.11%
TSE:ROMJ
Rubicon Organics
0.46
-0.12
-21.55%
TSE:AVCN
Avicanna
0.12
-0.13
-52.00%
Greenway Greenhouse Cannabis Corp. Corporate Events
Business Operations and StrategyFinancial Disclosures
Greenway boosts revenue and volumes as it refines premium cannabis portfolio
Positive
Aug 31, 2026
Greenway Greenhouse Cannabis Corp. reported first‑quarter fiscal 2027 net revenue of $2.23 million, up 38 per cent year over year, as grams sold reached a record 2.33 million. Despite a net loss of $659,893, the company delivered positive ad...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.